MedPath

ALGATECHNOLOGIES LTD

🇮🇱Israel
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

2 Phases

Early Phase 1:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Early Phase 1
1 (50.0%)
Not Applicable
1 (50.0%)

Oral Dietary Fucoxanthin Rich Supplement for Liver Health

Not Applicable
Conditions
Non Alcoholic Fatty Liver
First Posted Date
2018-08-10
Last Posted Date
2018-08-14
Lead Sponsor
Algatechnologies Ltd.
Target Recruit Count
30
Registration Number
NCT03625284

Bioavailability of Astaxanthin Formulations

Early Phase 1
Conditions
Healthy Volunteers
First Posted Date
2018-02-23
Last Posted Date
2019-05-21
Lead Sponsor
Algatechnologies Ltd.
Target Recruit Count
10
Registration Number
NCT03443882
Locations
🇮🇱

Bert W. Strassburger Lipid Center, Sheba Medical Center,, Tel Hashomer, Israel

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.